跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPROXEN CAPSULES 200 MG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NAPROXEN CAPSULES 200 MG
Authorized
STANDARD
NAPROXEN CAPSULES 200 MG
Accucaps Industries Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d3d6d1fe101ec8d1
Company
Accucaps Industries Ltd.
Type
Standard
Approval Details
Approval Id
d3d6d1fe101ec8d1
Drug Approval Canada Name
NAPROXEN CAPSULES 200 MG
Product Name
NAPROXEN CAPSULES 200 MG
Status
Cancelled Pre Market
Status Date
2019-06-03
Din
02422743
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE02 NAPROXEN
Atc Name
m 01 ae 02
Aig Number
0255210001
Company Name
Accucaps Industries Ltd.
Company Address
2125 Ambassador Drive, Windsor, Ontario, Canada, N9C 3R5
Company Detail Path
/organization/accucaps-industries-ltd
Company Information
Pharmaceutical Company Name
Accucaps Industries Ltd.
Country Name
Canada
Province Name
Ontario
City Name
windsor,ontario,country_ca
Address
2125 Ambassador Dr
Active Ingredients
NAPROXEN
105 MG
NAPROXEN SODIUM
105 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d3d6d1fe101ec8d1
Type
Standard
Back to Health Canada Approvals